Non-opioid therapeutic proteins for chronic neuropathic pain and hearing loss
Funding history
Date
Round
Amount
Dec 2023
Series A
Copenhagen biotech Hoba Therapeutics raised a 23M EUR Series A led by Indaco Venture Partners and Medical Incubator Japan to advance its non-opioid pain drug HB-086.
$24.8M
Investors
EIC FundEir VenturesExport and Investment Fund of DenmarkIndaco Venture PartnersMedical Incubator JapanNovo Holdings